✦ LIBER ✦

Intravitreal anti-VEGF therapy in neovascular age-related macular degeneration: Bevacizumab versus Ranibizumab

✍ Scribed by C. Zehetner; M. T. Kralinger; G. F. Kieselbach

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intravitreal bevacizumab therapy for neo

✍ Maura Lucy Abrahám-Marin; Carlos Fernando Cortés-Luna; Griselda Álvarez-Rivera; 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 208 KB

Combined intravitreal bevacizumab and ph

✍ Markus S. Ladewig; Stefanie E. Karl; Victoria Hamelmann; Hans-Martin Helb; Hendr 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 625 KB

Intravitreal bevacizumab (Avastin) for o

✍ S. Aisenbrey; F. Ziemssen; M. Völker; F. Gelisken; P. Szurman; G. Jaissle; S. Gr 📂 Article 📅 2006 🏛 Springer-Verlag 🌐 English ⚖ 569 KB

Predictors of response after intravitrea

✍ Yeo Jue Byun; Sung Jun Lee; Hyoung Jun Koh 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 392 KB

Retinal pigment epithelial tear followin

✍ Gary K. Y. Lee; Timothy Y. Y. Lai; Wai-Man Chan; Dennis S. C. Lam 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 167 KB

Ranibizumab for retinal angiomatous prol

✍ Timothy Y. Y. Lai; Wai-Man Chan; David T. Liu; Dennis S. Lam 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 205 KB